[1]
Wang GQ, Rui HL, Dong HR, Sun LJ, Yang M, Wang YY, Ye N, Zhao ZR, Liu XJ, Xu XY, Chen YP, Cheng H. SMRT sequencing revealed to be an effective method for ADTKD-MUC1 diagnosis through follow-up analysis of a Chinese family. Scientific reports. 2020 May 25:10(1):8616. doi: 10.1038/s41598-020-65491-2. Epub 2020 May 25
[PubMed PMID: 32451462]
[2]
Kirby A, Gnirke A, Jaffe DB, Barešová V, Pochet N, Blumenstiel B, Ye C, Aird D, Stevens C, Robinson JT, Cabili MN, Gat-Viks I, Kelliher E, Daza R, DeFelice M, Hůlková H, Sovová J, Vylet'al P, Antignac C, Guttman M, Handsaker RE, Perrin D, Steelman S, Sigurdsson S, Scheinman SJ, Sougnez C, Cibulskis K, Parkin M, Green T, Rossin E, Zody MC, Xavier RJ, Pollak MR, Alper SL, Lindblad-Toh K, Gabriel S, Hart PS, Regev A, Nusbaum C, Kmoch S, Bleyer AJ, Lander ES, Daly MJ. Mutations causing medullary cystic kidney disease type 1 lie in a large VNTR in MUC1 missed by massively parallel sequencing. Nature genetics. 2013 Mar:45(3):299-303. doi: 10.1038/ng.2543. Epub 2013 Feb 10
[PubMed PMID: 23396133]
[3]
Faguer S,Decramer S,Chassaing N,Bellanné-Chantelot C,Calvas P,Beaufils S,Bessenay L,Lengelé JP,Dahan K,Ronco P,Devuyst O,Chauveau D, Diagnosis, management, and prognosis of HNF1B nephropathy in adulthood. Kidney international. 2011 Oct;
[PubMed PMID: 21775974]
[4]
Devuyst O, Olinger E, Weber S, Eckardt KU, Kmoch S, Rampoldi L, Bleyer AJ. Autosomal dominant tubulointerstitial kidney disease. Nature reviews. Disease primers. 2019 Sep 5:5(1):60. doi: 10.1038/s41572-019-0109-9. Epub 2019 Sep 5
[PubMed PMID: 31488840]
[5]
Cormican S,Connaughton DM,Kennedy C,Murray S,Živná M,Kmoch S,Fennelly NK,O'Kelly P,Benson KA,Conlon ET,Cavalleri G,Foley C,Doyle B,Dorman A,Little MA,Lavin P,Kidd K,Bleyer AJ,Conlon PJ, Autosomal dominant tubulointerstitial kidney disease (ADTKD) in Ireland. Renal failure. 2019 Nov
[PubMed PMID: 31509055]
[6]
Bleyer AJ, Kidd K, Živná M, Kmoch S. Autosomal Dominant Tubulointerstitial Kidney Disease. Advances in chronic kidney disease. 2017 Mar:24(2):86-93. doi: 10.1053/j.ackd.2016.11.012. Epub
[PubMed PMID: 28284384]
[7]
Bollée G,Dahan K,Flamant M,Morinière V,Pawtowski A,Heidet L,Lacombe D,Devuyst O,Pirson Y,Antignac C,Knebelmann B, Phenotype and outcome in hereditary tubulointerstitial nephritis secondary to UMOD mutations. Clinical journal of the American Society of Nephrology : CJASN. 2011 Oct;
[PubMed PMID: 21868615]
[8]
Moskowitz JL,Piret SE,Lhotta K,Kitzler TM,Tashman AP,Velez E,Thakker RV,Kotanko P, Association between genotype and phenotype in uromodulin-associated kidney disease. Clinical journal of the American Society of Nephrology : CJASN. 2013 Aug;
[PubMed PMID: 23723338]
[9]
Mabillard H, Sayer JA, Olinger E. Clinical and genetic spectra of autosomal dominant tubulointerstitial kidney disease. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2023 Feb 13:38(2):271-282. doi: 10.1093/ndt/gfab268. Epub
[PubMed PMID: 34519781]
[10]
Gast C, Marinaki A, Arenas-Hernandez M, Campbell S, Seaby EG, Pengelly RJ, Gale DP, Connor TM, Bunyan DJ, Hodaňová K, Živná M, Kmoch S, Ennis S, Venkat-Raman G. Autosomal dominant tubulointerstitial kidney disease-UMOD is the most frequent non polycystic genetic kidney disease. BMC nephrology. 2018 Oct 30:19(1):301. doi: 10.1186/s12882-018-1107-y. Epub 2018 Oct 30
[PubMed PMID: 30376835]
[11]
Bernascone I,Janas S,Ikehata M,Trudu M,Corbelli A,Schaeffer C,Rastaldi MP,Devuyst O,Rampoldi L, A transgenic mouse model for uromodulin-associated kidney diseases shows specific tubulo-interstitial damage, urinary concentrating defect and renal failure. Human molecular genetics. 2010 Aug 1;
[PubMed PMID: 20472742]
[12]
Bernascone I, Vavassori S, Di Pentima A, Santambrogio S, Lamorte G, Amoroso A, Scolari F, Ghiggeri GM, Casari G, Polishchuk R, Rampoldi L. Defective intracellular trafficking of uromodulin mutant isoforms. Traffic (Copenhagen, Denmark). 2006 Nov:7(11):1567-79
[PubMed PMID: 17010121]
[13]
Rampoldi L, Scolari F, Amoroso A, Ghiggeri G, Devuyst O. The rediscovery of uromodulin (Tamm-Horsfall protein): from tubulointerstitial nephropathy to chronic kidney disease. Kidney international. 2011 Aug:80(4):338-47. doi: 10.1038/ki.2011.134. Epub 2011 Jun 8
[PubMed PMID: 21654721]
[14]
Mutig K,Kahl T,Saritas T,Godes M,Persson P,Bates J,Raffi H,Rampoldi L,Uchida S,Hille C,Dosche C,Kumar S,Castañeda-Bueno M,Gamba G,Bachmann S, Activation of the bumetanide-sensitive Na ,K ,2Cl- cotransporter (NKCC2) is facilitated by Tamm-Horsfall protein in a chloride-sensitive manner. The Journal of biological chemistry. 2011 Aug 26;
[PubMed PMID: 21737451]
[15]
Ectopic pregnancy following tubal sterilizations., Athari TA,Ravangard F,, The West Virginia medical journal, 1978 Sep
[PubMed PMID: 32954071]
[16]
Bolar NA, Golzio C, Živná M, Hayot G, Van Hemelrijk C, Schepers D, Vandeweyer G, Hoischen A, Huyghe JR, Raes A, Matthys E, Sys E, Azou M, Gubler MC, Praet M, Van Camp G, McFadden K, Pediaditakis I, Přistoupilová A, Hodaňová K, Vyleťal P, Hartmannová H, Stránecký V, Hůlková H, Barešová V, Jedličková I, Sovová J, Hnízda A, Kidd K, Bleyer AJ, Spong RS, Vande Walle J, Mortier G, Brunner H, Van Laer L, Kmoch S, Katsanis N, Loeys BL. Heterozygous Loss-of-Function SEC61A1 Mutations Cause Autosomal-Dominant Tubulo-Interstitial and Glomerulocystic Kidney Disease with Anemia. American journal of human genetics. 2016 Jul 7:99(1):174-87. doi: 10.1016/j.ajhg.2016.05.028. Epub
[PubMed PMID: 27392076]
[17]
Schaeffer C,Izzi C,Vettori A,Pasqualetto E,Cittaro D,Lazarevic D,Caridi G,Gnutti B,Mazza C,Jovine L,Scolari F,Rampoldi L, Autosomal Dominant Tubulointerstitial Kidney Disease with Adult Onset due to a Novel Renin Mutation Mapping in the Mature Protein. Scientific reports. 2019 Aug 12
[PubMed PMID: 31406136]
[18]
Izzi C,Dordoni C,Econimo L,Delbarba E,Grati FR,Martin E,Mazza C,Savoldi G,Rampoldi L,Alberici F,Scolari F, Variable Expressivity of HNF1B Nephropathy, From Renal Cysts and Diabetes to Medullary Sponge Kidney Through Tubulo-interstitial Kidney Disease. Kidney international reports. 2020 Dec
[PubMed PMID: 33305128]
[19]
Bleyer AJ, Kmoch S, Antignac C, Robins V, Kidd K, Kelsoe JR, Hladik G, Klemmer P, Knohl SJ, Scheinman SJ, Vo N, Santi A, Harris A, Canaday O, Weller N, Hulick PJ, Vogel K, Rahbari-Oskoui FF, Tuazon J, Deltas C, Somers D, Megarbane A, Kimmel PL, Sperati CJ, Orr-Urtreger A, Ben-Shachar S, Waugh DA, McGinn S, Bleyer AJ Jr, Hodanová K, Vylet'al P, Živná M, Hart TC, Hart PS. Variable clinical presentation of an MUC1 mutation causing medullary cystic kidney disease type 1. Clinical journal of the American Society of Nephrology : CJASN. 2014 Mar:9(3):527-35. doi: 10.2215/CJN.06380613. Epub 2014 Feb 7
[PubMed PMID: 24509297]
[20]
Ekici AB,Hackenbeck T,Morinière V,Pannes A,Buettner M,Uebe S,Janka R,Wiesener A,Hermann I,Grupp S,Hornberger M,Huber TB,Isbel N,Mangos G,McGinn S,Soreth-Rieke D,Beck BB,Uder M,Amann K,Antignac C,Reis A,Eckardt KU,Wiesener MS, Renal fibrosis is the common feature of autosomal dominant tubulointerstitial kidney diseases caused by mutations in mucin 1 or uromodulin. Kidney international. 2014 Sep;
[PubMed PMID: 24670410]
[21]
Nasr SH,Lucia JP,Galgano SJ,Markowitz GS,D'Agati VD, Uromodulin storage disease. Kidney international. 2008 Apr;
[PubMed PMID: 18004297]
[22]
Hoefele J, Nayir A, Chaki M, Imm A, Allen SJ, Otto EA, Hildebrandt F. Pseudodominant inheritance of nephronophthisis caused by a homozygous NPHP1 deletion. Pediatric nephrology (Berlin, Germany). 2011 Jun:26(6):967-71. doi: 10.1007/s00467-011-1761-9. Epub 2011 Jan 22
[PubMed PMID: 21258817]
[23]
Lens XM,Banet JF,Outeda P,Barrio-Lucía V, A novel pattern of mutation in uromodulin disorders: autosomal dominant medullary cystic kidney disease type 2, familial juvenile hyperuricemic nephropathy, and autosomal dominant glomerulocystic kidney disease. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2005 Jul;
[PubMed PMID: 15983957]
[24]
Bleyer AJ,Kmoch S,Adam MP,Ardinger HH,Pagon RA,Wallace SE,Bean LJH,Mirzaa G,Amemiya A, Autosomal Dominant Tubulointerstitial Kidney Disease, {i}MUC1{/i}-Related GeneReviews<sup>®</sup>. 1993
[PubMed PMID: 23946964]
[25]
Adam MP, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, Bleyer AJ, Kidd K, Živná M, Kmoch S. Autosomal Dominant Tubulointerstitial Kidney Disease – UMOD. GeneReviews(®). 1993:():
[PubMed PMID: 20301530]
[26]
[New ways for a dental service. A discussion with dental students]., Dreher J,, Zahnarzteblatt Baden-Wurttemberg, 1978 Apr
[PubMed PMID: 26319241]
[27]
Živná M, Kidd K, Přistoupilová A, Barešová V, DeFelice M, Blumenstiel B, Harden M, Conlon P, Lavin P, Connaughton DM, Hartmannová H, Hodaňová K, Stránecký V, Vrbacká A, Vyleťal P, Živný J, Votruba M, Sovová J, Hůlková H, Robins V, Perry R, Wenzel A, Beck BB, Seeman T, Viklický O, Rajnochová-Bloudíčková S, Papagregoriou G, Deltas CC, Alper SL, Greka A, Bleyer AJ, Kmoch S. Noninvasive Immunohistochemical Diagnosis and Novel MUC1 Mutations Causing Autosomal Dominant Tubulointerstitial Kidney Disease. Journal of the American Society of Nephrology : JASN. 2018 Sep:29(9):2418-2431. doi: 10.1681/ASN.2018020180. Epub 2018 Jul 2
[PubMed PMID: 29967284]
[28]
Stevens PE, Levin A, Kidney Disease: Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group Members. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Annals of internal medicine. 2013 Jun 4:158(11):825-30. doi: 10.7326/0003-4819-158-11-201306040-00007. Epub
[PubMed PMID: 23732715]
Level 1 (high-level) evidence
[29]
Eckardt KU,Alper SL,Antignac C,Bleyer AJ,Chauveau D,Dahan K,Deltas C,Hosking A,Kmoch S,Rampoldi L,Wiesener M,Wolf MT,Devuyst O,Kidney Disease: Improving Global Outcomes., Autosomal dominant tubulointerstitial kidney disease: diagnosis, classification, and management--A KDIGO consensus report. Kidney international. 2015 Oct
[PubMed PMID: 25738250]
Level 3 (low-level) evidence
[30]
Hoeltzenbein M, Stieler K, Panse M, Wacker E, Schaefer C. Allopurinol Use during Pregnancy - Outcome of 31 Prospectively Ascertained Cases and a Phenotype Possibly Indicative for Teratogenicity. PloS one. 2013:8(6):e66637. doi: 10.1371/journal.pone.0066637. Epub 2013 Jun 19
[PubMed PMID: 23840514]
Level 3 (low-level) evidence
[31]
Faguer S, Chassaing N, Bandin F, Prouheze C, Garnier A, Casemayou A, Huart A, Schanstra JP, Calvas P, Decramer S, Chauveau D. The HNF1B score is a simple tool to select patients for HNF1B gene analysis. Kidney international. 2014 Nov:86(5):1007-15. doi: 10.1038/ki.2014.202. Epub 2014 Jun 4
[PubMed PMID: 24897035]
Level 3 (low-level) evidence